Implications of the 2017 AAP Clinical Practice Guidelines for Management of Hypertension in Children and Adolescents: a Review

  • Eliza Blanchette
  • Joseph T. FlynnEmail author
Pediatric Hypertension (B Falkner, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Pediatric Hypertension


Purpose of Review

To evaluate the impact of the 2017 American Academy of Pediatrics Clinical Practice Guideline (2017 AAP CPG) for Screening and Management of High Blood Pressure in Children and Adolescents.

Recent Findings

The 2017 AAP CPG had several significant changes compared to the 2004 Fourth Report. This review will focus on the emerging evidence from the first studies to apply the 2017 AAP CPG and the simplified table it contains on the overall prevalence of HTN and on recognition among children and adolescents at a higher cardiovascular risk.


Recent evidence suggests that use of the 2017 AAP CPG will result in an overall increase in prevalence of HTN, particularly in youth who are obese or who have other cardiovascular risk factors. The change in prevalence likely differs based on sex, age, and height. The ability for the 2017 AAP CPG to detect an association with hypertension and target organ damage requires further study. Continued study is required to assess long-term implications of the 2017 AAP CPG with the goal of a more meaningful HTN definition in the young.


Pediatric hypertension Elevated blood pressure Stage 1 hypertension Stage 2 hypertension Secondary hypertension Prevalence of hypertension Abnormal left ventricular geometry 2017 AAP Clinical Practice Guideline for High Blood Pressure in Children and Adolescents 



This work was supported in part by NIH T32DK997662 (EB).

Compliance with Ethical Standards

Conflict of Interest

The authors declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    National High Blood Pressure Education Program Working Group. Fourth Report On The Diagnosis, Evaluation, And Treatment Of High Blood Pressure In Children And Adolescents. Pediatrics [Internet]. 2004;114:555–76. Available from:
  2. 2.
    de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol. Elsevier Masson SAS. 1992;20:1251–60. Scholar
  3. 3.
    Shah AS, Khoury PR, Dolan LM, Ippisch HM, Urbina EM, Daniels SR, et al. The effects of obesity and type 2 diabetes mellitus on cardiac structure and function in adolescents and young adults. Diabetologia. 2011;54:722–30.CrossRefGoogle Scholar
  4. 4.
    •• Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140:e20171904. The publication of the 2017 AAP CPG.CrossRefPubMedGoogle Scholar
  5. 5.
    Whelton PK, Carey RM, Aronow WS, Casey DE, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task F. Circulation. 2018.Google Scholar
  6. 6.
    Dionne J. Updated guideline may improve the recognition and diagnosis of hypertension in children and adolescents; review of the 2017 AAP blood pressure clinical practice guideline. Curr Hypertens Rep. 2017;19.Google Scholar
  7. 7.
    Daniels SR. What is the prevalence of childhood hypertension? It depends on the definition. JAMA Pediatr. 2018;172:519–20.CrossRefGoogle Scholar
  8. 8.
    Kharbanda EO, Asche SE, Sinaiko AR, Ekstrom HL, Nordin JD, Sherwood NE, et al. Clinical decision support for recognition and management of hypertension: a randomized trial. Pediatrics. 2018;141:e20172954. Scholar
  9. 9.
    Flynn JT, Daniels SR, Hayman LL, Maahs DM, Mccrindle BW, Mitsnefes M, et al. Update : ambulatory blood pressure monitoring in children and adolescents. Hypertension. 2014;63:1116–35.CrossRefGoogle Scholar
  10. 10.
    Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 2002;39:903–8.CrossRefGoogle Scholar
  11. 11.
    Macumber I. Ambulatory blood pressure monitoring in children and adolescents: a review of recent literature and new guidelines. Curr Hypertens Rep. 2017;19:96.CrossRefGoogle Scholar
  12. 12.
    Samuels J, Samuel J. New guidelines for hypertension in children and adolescents. J Clin Hypertens. 2018:1–3.Google Scholar
  13. 13.
    Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT, et al. Potential U.S. population impact of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline. J Am Coll Cardiol. 2017;71:109–18 Available from: Scholar
  14. 14.
    Miyashita Y, Hanevold C. Evaluation and management of stage 2 hypertension in pediatric patients. Curr Hypertens Rep. 2018;20:73.CrossRefGoogle Scholar
  15. 15.
    Brady TM, Stefani-Glücksberg A, Simonetti GD. Management of high blood pressure in children: similarities and differences between US and European guidelines. Pediatr Nephrol. 2018.Google Scholar
  16. 16.
    • Sharma AK, Metzger DL, Rodd CJ. Prevalence and severity of high blood pressure among children based on the 2017 American academy of pediatrics guidelines. JAMA Pediatr. 2018;172:557–65 Cross-sectional study using NHANES data to look at impact of the 2017 AAP CPG as compared to Fourth Report on prevalence of HBP and association with CVD risk factors in children and adolescents.CrossRefGoogle Scholar
  17. 17.
    • Khoury M, Khoury PR, Dolan LM, Kimball TR, Urbina EM. Clinical implications of the revised AAP pediatric hypertension guidelines. Pediatrics. 2018;142 Cross-sectional study evaluating the impact of the 2017 AAP CPG on prevalence of HTN and on recognition of HTN in high-risk CVD patients among a high-risk population.Google Scholar
  18. 18.
    • Dong Y, Song Y, Zou Z, Ma J, Dong B, Prochaska JJ. Updates to pediatric hypertension guidelines: influence on classification of high blood pressure in children and adolescents. J Hypertens. 2018;36:000–000 Cross-sectional study on Chinese youth investigating the change in prevalence and differential classification of children and adolescents with the 2017 AAP CPG.Google Scholar
  19. 19.
    Gupta-Malhotra M, Shete S, Barratt MS, Milewicz D, Hashmi SS. Epidemiology of childhood onset essential hypertension. J Hum Hypertens. Springer US. 2018;32:808–13. Scholar
  20. 20.
    • Al Kibria GM, Swasey K, Sharmeen A, Day B. Estimated change in prevalence and trends of childhood blood pressure levels in the United States after application of the 2017 AAP guideline. Prev Chronic Dis. 2019;16 Available from:, Cross-sectional study looking at the impact of the 2017 AAP CPG on prevalence of HTN during two time periods with NHANES.
  21. 21.
    • Bell CS, Samuel JP, Samuels JA. Prevalence of hypertension in children. Hypertension. 2019;73:148–52. Cohort study investigating the change in prevalence of HTN with the 2017 AAP CPG in a school-based screening program in Houston.CrossRefPubMedGoogle Scholar
  22. 22.
    Yang L, Hou Y, Zhao M, Bovet P, Xi B. Simplified blood pressure tables based on different height percentiles for screening elevated blood pressure in children. J Hypertens. 2018;37:292–6.CrossRefGoogle Scholar
  23. 23.
    Flynn JT, Kaelber DC, Baker-Smith CM. The simplified table in the 2017 American Academy of Pediatrics childhood hypertension guideline performs exactly as intended. J Hypertens. 2018;36:2478–80.CrossRefGoogle Scholar
  24. 24.
    Flynn JT, Falkner BE. New clinical practice guideline for the management of high blood pressure in children and adolescents. Hypertension. 2017;70:6883–686. Scholar
  25. 25.
    Lurbe E, Litwin M, Pall D, Seeman T, Stabouli S, Webb NJA, et al. Insights and implications of new blood pressure guidelines in children and adolescents. J Hypertens. 2018;36:1456–9.CrossRefGoogle Scholar
  26. 26.
    • Di Bonito P, Valerio G, Pacifico L, Chiesa C, Invitti C, Morandi A, et al. Impact of the 2017 blood pressure guidelines by the American Academy of Pediatrics in overweight/obese youth. J Hypertens. 2018;36:000–000 Available from: Cross-sectional study evaluating the impact of the 2017 AAP CPG on prevalence of HTN and also classification of those with HTN and ALVG in the 2017 AAP CPG as compared to the 2016 ESHG.Google Scholar
  27. 27.
    Litwin M, Niemirska A, Joanna Ś, Wierzbicka A, Janas R, Wawer ZT, et al. Regression of target organ damage in children and adolescents with primary hypertension. Pediatr Nephrol. 2010;25:2489–99.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of PediatricsUniversity of Washington School of MedicineSeattleUSA
  2. 2.Division of NephrologySeattle Children’s HospitalSeattleUSA

Personalised recommendations